Brenner DA - Search Results

1

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.

Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Fouts DE, et al. Among authors: brenner da. J Hepatol. 2012 Jun;56(6):1283-92. doi: 10.1016/j.jhep.2012.01.019. Epub 2012 Feb 9. J Hepatol. 2012. PMID: 22326468 Free PMC article.

2

The role of Smad3 in mediating mouse hepatic stellate cell activation.

Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. Schnabl B, et al. Among authors: brenner da. Hepatology. 2001 Jul;34(1):89-100. doi: 10.1053/jhep.2001.25349. Hepatology. 2001. PMID: 11431738

3

TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells.

Schnabl B, Bradham CA, Bennett BL, Manning AM, Stefanovic B, Brenner DA. Schnabl B, et al. Among authors: brenner da. Hepatology. 2001 Nov;34(5):953-63. doi: 10.1053/jhep.2001.28790. Hepatology. 2001. PMID: 11679966

4

Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy.

Stefanovic B, Schnabl B, Brenner DA. Stefanovic B, et al. Among authors: brenner da. J Biol Chem. 2002 May 17;277(20):18229-37. doi: 10.1074/jbc.M108065200. Epub 2002 Mar 11. J Biol Chem. 2002. PMID: 11889120 Free article.

5

Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype.

Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Schnabl B, et al. Hepatology. 2003 Mar;37(3):653-64. doi: 10.1053/jhep.2003.50097. Hepatology. 2003. PMID: 12601363

6

Gliotoxin-mediated apoptosis of activated human hepatic stellate cells.

Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Kweon YO, et al. Among authors: brenner da. J Hepatol. 2003 Jul;39(1):38-46. doi: 10.1016/s0168-8278(03)00178-8. J Hepatol. 2003. PMID: 12821042

7

Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.

Tacke F, Gäbele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C, Brenner DA, Schölmerich J, Schnabl B. Tacke F, et al. Among authors: brenner da. Dig Dis Sci. 2007 Dec;52(12):3404-15. doi: 10.1007/s10620-007-9758-8. Epub 2007 Apr 6. Dig Dis Sci. 2007. PMID: 17415633

8

Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.

Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Tacke F, et al. Among authors: brenner da. J Gastroenterol Hepatol. 2007 Aug;22(8):1256-64. doi: 10.1111/j.1440-1746.2006.04621.x. J Gastroenterol Hepatol. 2007. PMID: 17688666

9

What is the potential role of antifibrotic agents for the treatment of liver disease?

Schnabl B, Scholten D, Brenner DA. Schnabl B, et al. Among authors: brenner da. Nat Clin Pract Gastroenterol Hepatol. 2008 Sep;5(9):496-7. doi: 10.1038/ncpgasthep1200. Epub 2008 Jul 15. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18628735 No abstract available.

10

Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.

Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Miura K, et al. Among authors: brenner da. Hepatology. 2008 Nov;48(5):1420-9. doi: 10.1002/hep.22486. Hepatology. 2008. PMID: 18671304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters